Rituximab-responsive Guillain-Barré syndrome following allogeneic hematopoietic SCT
Bone Marrow Transplantation
|April 9, 2008
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts.
Bone marrow transplantation·2015
Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT.
Bone marrow transplantation·2015
Association between serum ferritin and microalbuminuria in Type 2 diabetes in Taiwan.
Diabetic medicine : a journal of the British Diabetic Association·2013
GVHD prophylaxis and incidence in contemporary alloHSCT: a large real-world GETH/TC analysis.
Bone marrow transplantation·2026
Antibody deficiency in myotonic dystrophy type 1: A differential diagnosis below the radar.
Journal of human immunity·2026
Birt-Hogg- Dubé Syndrome Masquerading as Multiple Infected Pulmonary Cysts.
QJM : monthly journal of the Association of Physicians·2026
Tocilizumab for refractory cerebral arteritis in a patient with systemic lupus erythematosus: A case report.
Modern rheumatology case reports·2026
Risk and characteristics of interstitial lung disease in patients with inflammatory bowel disease: A retrospective cohort study.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG·2026
